[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 569977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 222924, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 390117, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 570059, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 9, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.11, "open": 1.13, "dayLow": 1.04, "dayHigh": 1.14, "regularMarketPreviousClose": 1.11, "regularMarketOpen": 1.13, "regularMarketDayLow": 1.04, "regularMarketDayHigh": 1.14, "payoutRatio": 0.0, "beta": 0.608, "forwardPE": -3.516129, "volume": 987227, "regularMarketVolume": 987227, "averageVolume": 708824, "averageVolume10days": 876510, "averageDailyVolume10Day": 876510, "bid": 1.04, "ask": 1.13, "bidSize": 6, "askSize": 1, "marketCap": 93326344, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 2.63, "fiftyDayAverage": 1.26892, "twoHundredDayAverage": 1.250765, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 73212600, "profitMargins": 0.0, "floatShares": 80679184, "sharesOutstanding": 83729400, "sharesShort": 1867823, "sharesShortPriorMonth": 1723937, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0223, "heldPercentInsiders": 0.042930003, "heldPercentInstitutions": 0.085319996, "shortRatio": 1.74, "shortPercentOfFloat": 0.0231, "impliedSharesOutstanding": 85620496, "bookValue": 0.143, "priceToBook": 7.6223774, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -37548816, "trailingEps": -0.35, "forwardEps": -0.31, "enterpriseToEbitda": -1.822, "52WeekChange": -0.45226133, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 1.09, "targetHighPrice": 9.937088, "targetLowPrice": 7.985393, "targetMeanPrice": 8.84048, "targetMedianPrice": 8.71972, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 18195052, "totalCashPerShare": 0.217, "ebitda": -40178008, "totalDebt": 142554, "quickRatio": 2.303, "currentRatio": 2.465, "debtToEquity": 1.207, "returnOnAssets": -1.08743, "returnOnEquity": -2.76409, "freeCashflow": -12288195, "operatingCashflow": -25066712, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": -0.91743, "postMarketPrice": 1.08, "postMarketChange": -0.00999999, "regularMarketChange": -0.02, "regularMarketDayRange": "1.04 - 1.14", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 708824, "fiftyTwoWeekLowChange": 0.319, "fiftyTwoWeekLowChangePercent": 0.41374838, "fiftyTwoWeekRange": "0.771 - 2.63", "fiftyTwoWeekHighChange": -1.5400001, "fiftyTwoWeekHighChangePercent": -0.5855513, "fiftyTwoWeekChangePercent": -45.22613, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.35, "epsForward": -0.31, "epsCurrentYear": -0.42, "priceEpsCurrentYear": -2.5952382, "fiftyDayAverageChange": -0.17891991, "fiftyDayAverageChangePercent": -0.14100173, "twoHundredDayAverageChange": -0.16076493, "twoHundredDayAverageChangePercent": -0.12853329, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "cryptoTradeable": false, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -1.8018, "regularMarketPrice": 1.09, "corporateActions": [], "postMarketTime": 1757114916, "regularMarketTime": 1757102401, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]